Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Cancer stem cell

  • Open Access
    High Expression of CD58 and ALDH1A3 Predicts a Poor Prognosis in Basal-like Breast Cancer
    YUYUN XIONG, HITOMI MOTOMURA, SHOMA TAMORI, AYAKA OZAKI, CHOTARO ONAGA, YASUSHI HARA, KEIKO SATO, KOUJI TAHATA, YOHSUKE HARADA, KAZUNORI SASAKI, YUN-WEN ZHENG, SHIGEO OHNO and KAZUNORI AKIMOTO
    Anticancer Research November 2022, 42 (11) 5223-5232; DOI: https://doi.org/10.21873/anticanres.16029
  • You have access
    Evidence of Potential Plant-derived Compounds With Anticancer Effects on Lung Cancer: Clinical and Molecular Pharmacology Approaches
    MONRUEDEE SUKPRASANSAP and PITHI CHANVORACHOTE
    Anticancer Research September 2022, 42 (9) 4247-4258; DOI: https://doi.org/10.21873/anticanres.15924
  • Open Access
    High Expression of p62 and ALDH1A3 Is Associated With Poor Prognosis in Luminal B Breast Cancer
    AYAKA OZAKI, HITOMI MOTOMURA, SHOMA TAMORI, CHOTARO ONAGA, YUKA NAGASHIMA, MAHO KOTORI, CHIKA MATSUDA, AKARI MATSUDA, NANAKO MOCHIZUKI, TSUGUMICHI SATO, YASUSHI HARA, KEIKO SATO, YOHEI MIYAGI, YOJI NAGASHIMA, TAKEHISA HANAWA, YOHSUKE HARADA, YUYUN XIONG, KAZUNORI SASAKI, SHIGEO OHNO and KAZUNORI AKIMOTO
    Anticancer Research July 2022, 42 (7) 3299-3312; DOI: https://doi.org/10.21873/anticanres.15818
  • You have access
    Polycomb Protein BMI-1 as a Potential Therapeutic Target in Mucinous Ovarian Cancer
    SALEM ABOBAKER, HAGEN KULBE, ELIANE T. TAUBE, SILVIA DARB-ESFAHANI, ROLF RICHTER, CARSTEN DENKERT, PAUL JANK, JALID SEHOULI and ELENA IOANA BRAICU
    Anticancer Research April 2022, 42 (4) 1739-1747; DOI: https://doi.org/10.21873/anticanres.15650
  • You have access
    GLO 1 and PKCĪ» Regulate ALDH1-positive Breast Cancer Stem Cell Survival
    HITOMI MOTOMURA, SHOMA TAMORI, MASA-AKI YATANI, AYANO NAMIKI, CHOTARO ONAGA, AYAKA OZAKI, RYOKO TAKASAWA, YASUNARI MANO, TSUGUMICHI SATO, YASUSHI HARA, KEIKO SATO, YUYUN XIONG, YOHSUKE HARADA, TAKEHISA HANAWA, SEI-ICHI TANUMA, KAZUNORI SASAKI, SHIGEO OHNO and KAZUNORI AKIMOTO
    Anticancer Research December 2021, 41 (12) 5959-5971; DOI: https://doi.org/10.21873/anticanres.15415
  • You have access
    Linker Threonine-phosphorylated Smad2/3 Is a Biomarker of Colorectal Neoplastic Stem-like Cells that Correlates With Carcinogenesis
    SACHI MIYAMOTO, TOSHIRO FUKUI, SHUNSUKE HORITANI, YUJI TANIMURA, YASUSHI MATSUMOTO, RYO SUZUKI, YU TAKAHASHI, MASANOBU KISHIMOTO, TAKASHI TOMIYAMA, AKIYOSHI NISHIO, KAZUICHI OKAZAKI and MAKOTO NAGANUMA
    Anticancer Research October 2021, 41 (10) 4789-4799; DOI: https://doi.org/10.21873/anticanres.15294
  • You have access
    Effects of Concurrent Chemoradiotherapy on the Metastasis and the Mesenchymal Transition of Bladder Urothelial Carcinoma Cells
    YUEH PAN, YING CHUI HONG, CHI-HAO HSIAO, HUNG-JEN SHIH, SHENG-HSIEN HUANG, SHENG-CHUAN WU, CHIN-PAO CHANG, SHAO-CHI CHIU, DER-YANG CHO and PING-HSIAO SHIH
    Anticancer Research October 2021, 41 (10) 4957-4968; DOI: https://doi.org/10.21873/anticanres.15309
  • You have access
    Simple Cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma
    KYOSUKE AGAWA, KIMIHIRO YAMASHITA, AKIO NAKAGAWA, KOUTA YAMADA, AKIHIRO WATANABE, JUNKO MUKOHYAMA, MASAFUMI SAITO, MITSUGU FUJITA, GOSUKE TAKIGUCHI, NAOKI URAKAWA, HIROSHI HASEGAWA, SHINGO KANAJI, TAKERU MATSUDA, TARO OSHIKIRI, TETSU NAKAMURA, SATOSHI SUZUKI and YOSHIHIRO KAKEJI
    Anticancer Research August 2021, 41 (8) 4117-4126; DOI: https://doi.org/10.21873/anticanres.15214
  • You have access
    HOXB5 Confers Tamoxifen Resistance in Breast Cancer Cells and Promotes Tumor Aggression and Progression
    CLARA YURI KIM, YU CHEON KIM, JI HOON OH and MYOUNG HEE KIM
    Anticancer Research July 2021, 41 (7) 3409-3417; DOI: https://doi.org/10.21873/anticanres.15128
  • You have access
    PrPC Regulates the Cancer Stem Cell Properties via Interaction With c-Met in Colorectal Cancer Cells
    JI HO LIM, GYEONGYUN GO and SANG HUN LEE
    Anticancer Research July 2021, 41 (7) 3459-3470; DOI: https://doi.org/10.21873/anticanres.15133

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire